Upcoming event

Disrupt your lunch 2023!

To start 2023 in a disruptive way join our inspiring lunch with Kees Klomp!

Lines

Sustainable medical mouth-nose masks

The focus of this project is to bring a new type of FFP2 mask, the Pro-Mouth-nose mask, to the market. This mask is more sustainable than other masks and offers a higher guarantee of delivery as the entire production chain will take place in Europe.

Start year 2021
End year 2022

About the project

The project started with a feasibility study on market introduction. The mouth-nose mask is an innovative product that is made almost entirely (95%) from biological renewable raw materials: PLA with bio-PP for a filtering effect and recycled steel for the nose bridge. As the mouth-nose mask is 20-45% lighter, less raw materials are used.

The development and production of the new ProM mask will be more sustainable by using the knowledge and skills of previous in-house development and production processes combined with the knowledge and expertise of prominent Dutch scientific knowledge and training institutes.

Together, we aim for a sustainable future by making and keeping innovative, sustainable mouth-nose masks available for healthcare in the Netherlands and, where possible, the rest of Europe.

We have been able to produce a new affordable and sustainable FFP2 medical mask. These masks are ready to be tested and certified by the proper notified bodies in 2023 and may eventually be brought to the market.

This research is supported by Small Business Innovation Research (SBIR) of the Netherlands Enterprise Agency (RVO).

Lines

MEDICAID

Partners

Start year 2018
Lines

PerStim

Partners

Start year 2018

A non-invasive approach to treatment

Using EEG- and MR-imaging based transcranial electrical stimulation, the Eindhoven Engine project PerStim (Personalized neurostimulation) investigates how treatments for patients with refractory focal epilepsy and prevalent co-morbid disorders can be personalized effectively. Via transcutaneous direct/alternating current stimulation (tDCS/tACS), the overall aim is to develop personalized, non-invasive neurostimulation protocols to provide (non-)refractory epilepsy patients with a better quality of life. This non-invasive approach to treatment is a method whereby an operation is not needed and treatment outside the body, as it were, is made possible.

Tight technical-clinical cooperation

To realize these ambitions, TU/e has teamed up with Philips Electronics Nederland B.V. and Kempenhaeghe, the Academic Center for Epileptology. UZ Ghent is also involved through the part-time neuromodulation chair of Professor Paul Boon. PPP Allowance co-funding has been made available to Epilepsiefonds by Health~Holland’s Top Sector Life Sciences & Health in order to stimulate public-private partnerships. Project partner meetings take place approximately once per month, with Fontys and TU/e student projects expected to be held in Eindhoven Engine’s building Disruptor. Such close collaboration and the integration of their results in clinical trials will allow for direct testing of PerStim’s neurostimulation hypothesis.

Videos

Rob Mestrom – Project Leader

Steven Beumer – PhD candidate

Lines

PerStim

Partners

Start year 2018
Lines

PerStim

Partners

Start year 2018
Lines

PerStim

Partners

Start year 2018
Lines

PerStim

Partners

Start year 2018

Our mission

Every year, 800.000 babies are born extremely preterm (<28 weeks of age) worldwide. These infants are usually transferred to an air-based neonatal intensive care unit to support their heart and lung development. Exposure to air, however, leads to many complications, because the lungs are not fully developed yet.
In cooperation with our partners, we develop a novel, alternative environment, more similar to the mother’s womb. Extremely premature babies would be transferred to an environment where the lungs remain filled with fluid and the umbilical cord will be attached to an artificial placenta to improve their organ development and ease the transition to newborn life. Our mission is to improve neonatal healthcare with our products.

More project info

Lines

PerStim

Partners

Start year 2018

Videos

Marieke van Beurden – Project leader

Steven Vos – Professor

Hans Brombacher – PhD candidate

Lines

AUXSTENT

Unlocking mechanical limitations of synthetic heart stents with auxetic,
fiber tubular scaffolds.

Partners

Start year 2022

Lines

WECARE

Partners:

Start year 2022